Quality of probiotic products for preterm infants: Contamination and missing strains

Acta Paediatrica, International Journal of Paediatrics

Volumn 109, Issue 2, 2020, Pages 276-279

  Vermeulen, Marijn J ^a   Luijendijk, Ad ^b   van Toledo, Letty ^c   van Kaam, Anton H ^c   Reiss, Irwin K M ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

contamination; Infloran; necrotising enterocolitis; probiotics; safety

Indexed keywords

PROBIOTIC AGENT;

ARTICLE; BACTERIAL STRAIN; BACTERIUM CONTAMINATION; CLINICAL TRIAL (TOPIC); HUMAN; INFANT; META ANALYSIS (TOPIC); NONHUMAN; PREMATURITY; PRIORITY JOURNAL; PRODUCT QUALITY; PRODUCT SAFETY; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN DISEASE;

ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFANT, PREMATURE; PROBIOTICS;

EID: 85074436591     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/apa.14976     Document Type: Article

References (27)

1. Patel RM, Underwood MA. Probiotics and necrotizing enterocolitis. Semin Pediatr Surg. 2018;27:39-46.
2. Viswanathan S, Lau C, Akbari H, Hoyen C, Walsh MC. Survey and evidence based review of probiotics used in very low birth weight preterm infants within the United States. J Perinatol. 2016;36:1106-1111.
3. Denkel LA, Schwab F, Garten L, Geffers C, Gastmeier P, Piening B. Protective effect of dual-strain probiotics in preterm infants: a multi-center time series analysis. PLoS ONE. 2016;11:e0158136.
4. van den Akker CHP, van Goudoever JB, Szajewska H, et al. Probiotics for preterm infants: a strain specific systematic review and network meta-analysis. J Pediatr Gastroenterol Nutr. 2018;67(1):103-122.
5. Bafeta A, Koh M, Riveros C, Ravaud P. Harms reporting in randomized controlled trials of interventions aimed at modifying microbiota: a systematic review. Ann Intern Med. 2018;169:240-247.
6. Costa RL, Moreira J, Lorenzo A, Lamas CC. Infectious complications following probiotic ingestion: a potentially underestimated problem? A systematic review of reports and case series. BMC Complement Altern Med. 2018;18:329.
7. Kunz AN, Noel JM, Fairchok MP. Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J Pediatr Gastroenterol Nutr. 2004;38:457-458.
8. Ohishi A, Takahashi S, Ito Y, et al. Bifidobacterium septicemia associated with postoperative probiotic therapy in a neonate with omphalocele. J Pediatr. 2010;156:679-681.
9. Esaiassen E, Cavanagh P, Hjerde E, Simonsen GS, Stoen R, Klingenberg C. Bifidobacterium longum Subspecies infantis Bacteremia in 3 extremely preterm infants receiving probiotics. Emerg Infect Dis. 2016;22:1664-1666.
10. Sanders ME, Merenstein DJ, Ouwehand AC, et al. Probiotic use in at-risk populations. J Am Pharm Assoc. 2003;2016(56):680-686.
11. Besselink MGH, van Santvoort HC, Buskens E, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;371:651-659.
12. Samuels N, van de Graaf R, Been JV, et al. Necrotising enterocolitis and mortality in preterm infants after introduction of probiotics: a quasi-experimental study. Sci Rep. 2016;6:31643.
13. Lin HC, Hsu CH, Chen HL, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics. 2008;122:693-700.
14. Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW. Manual of Clinical Microbiology, 10th edn. Washington, DC: American Society for Microbiology; 2011:1. ISBN 978-1-55581-463-2.
15. Vallabhaneni S, Walker TA, Lockhart SR, et al. Notes from the field: fatal gastrointestinal mucormycosis in a premature infant associated with a contaminated dietary supplement–Connecticut, 2014. MMWR Morb Mortal Wkly Rep. 2015;64:155-156.
16. Barton LL, Rider ED, Coen RW. Bacteremic infection with Pediococcus: vancomycin-resistant opportunist. Pediatrics. 2001;107:775-776.
17. Brecht M, Garg A, Longstaff K, Cooper C, Andersen C. Lactobacillus sepsis following a laparotomy in a preterm infant: a note of caution. Neonatology. 2016;109:186-189.
18. Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110:285-291.
19. Downey LC, Smith PB, Benjamin DK Jr. Risk factors and prevention of late-onset sepsis in premature infants. Early Hum Dev. 2010;86(Suppl 1):7-12.
20. Song AA, In L, Lim S, Rahim RA. A review on Lactococcus lactis: from food to factory. Microb Cell Fact. 2017;16:55.
21. Malek A, De la Hoz A, Gomez-Villegas SI, Nowbakht C, Arias CA. Lactococcus garvieae, an unusual pathogen in infective endocarditis: case report and review of the literature. BMC Infect Dis. 2019;19:301.
22. European Directorate for the Quality of Medicines. The European Pharmacopoeia: Microbiological quality of non-sterile pharmaceutical preparations and substances for pharmaceutical use, 10th edn. Strasbourg, France: The European Pharmacopoeia; 2019:627-628.
23. World Health Organization. The International Pharmacopeia, 4th edn. S.3.7 ed2012.
24. Jackson SA, Schoeni JL, Vegge C, et al. Improving end-user trust in the quality of commercial probiotic products. Front Microbiol. 2019;10:739.
25. Lewis ZT, Shani G, Masarweh CF, et al. Validating bifidobacterial species and subspecies identity in commercial probiotic products. Pediatr Res. 2016;79:445-452.
26. Morovic W, Hibberd AA, Zabel B, Barrangou R, Stahl B. Genotyping by PCR and high-throughput sequencing of commercial probiotic products reveals composition biases. Front Microbiol. 2016;7:1747.
27. Angelakis E, Million M, Henry M, Raoult D. Rapid and accurate bacterial identification in probiotics and yoghurts by MALDI-TOF mass spectrometry. J Food Sci. 2011;76:M568-M572.